ToMotion AI logo
Menu
Back to gallery

Public AI explainer video

Understanding the Four Phases of Clinical Trials

How did a medicine you take earn its place in care? Before human trials, preclinical research tests potential medicines in labs and often animals. It...

Prompt

Source idea used to generate this video.

The Four Phases of Clinical Research: From Drug Discovery to Patient Care Video Title: Understanding the Four Phases of Clinical Trials. Create a comprehensive, scientifically accurate educational video explaining all four phases of clinical trials in detail. Explain the purpose, objectives, study design, participant selection, methodology, safety monitoring, regulatory requirements, outcome measures, challenges, and real-world examples for each phase. Use clear, simple English suitable for beginners while maintaining the scientific depth required for clinical research education. Include realistic laboratory settings, pharmaceutical research facilities, hospitals, clinical trial sites, doctors interacting with participants, clinical research coordinators, investigators, research nurses, pharmacists, data managers, and regulatory professionals. Use animated diagrams to explain how a potential new drug progresses from early human testing to large-scale clinical trials and post-marketing surveillance. Clearly distinguish between preclinical research and the four phases of human clinical trials. Explain that not every drug follows an identical pathway and that clinical development varies according to the product, disease, regulatory pathway, and evidence required.

Narration

Narration used to create this video.

Video narration

How did a medicine you take earn its place in care? Before human trials, preclinical research tests potential medicines in labs and often animals. It is not a human-trial phase. Phase I asks: what dose is tolerable, and what safety concerns appear? It often involves a small group; participants are not always healthy volunteers. Phase II studies people with the condition for early signs of benefit, while checking safety. Phase III tests benefit and risk in larger groups, often comparing treatment with another option or control, building evidence for regulators. If regulators authorize use, Phase IV follows in wider, routine care, monitoring safety and how well the medicine works. These are different questions, not four identical hurdles-and finishing them does not guarantee approval. Evidence supports use only if regulators authorize it; the route varies with the product, disease, and pathway.